A real-world study presented at Psych Congress found that zuranolone's PPD symptom improvements were sustained through day 90.
|Articles|July 19, 2016
Is the 39-week rule good or bad? (VIDEO)
For Contemporary OB/GYN, Dr Bobby Lazzara looks at the question of whether reducing term births before 39 weeks' gestation leads to a significant increase in the rate of stillbirths and how it may impact practice.
Advertisement
For Contemporary OB/GYN, Dr Bobby Lazzara looks at the question of whether reducing term births before 39 weeks' gestation leads to a significant increase in the rate of stillbirths and how it may impact practice.
Advertisement
Related to this article
Maternal RSV immunization creates an important opportunity for obstetric and pediatric clinicians to coordinate newborn prevention strategies, according to Kevin Ault, MD.
Drawing on her own successful version, Amber Watters, MD, welcomes the ASA's push for closer obstetrics and anesthesia collaboration.
SMFM states abortion care is core to MFM practice and urges institutional action to protect high-risk patient access.
Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.
Amber Watters, MD, MS, explains that emergent delivery after external cephalic version is exceedingly rare and fits within existing protocols, and outlines how to build a version program.
Positively Pregnant translates cycle day and cycle length research into individualized pregnancy test sensitivity estimates, according to Alexandra C. Sundermann, MD, PhD.
Kevin Ault, MD, FACOG, explains that all four vaccines in ACOG's 2026-27 guidance carry direct newborn benefit and that prenatal conversations ease downstream pediatric vaccine discussions.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Zuranolone shows sustained PPD symptom improvement through day 90
2
Survey: 51% of US-women report negative healthcare experiences
3
Emotional and cognitive symptoms are redefining perimenopause recognition
4
Contemporary OB/GYN Weekly Review: Testosterone evidence, ECV counseling, and more
5